You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》裏昂上調康龍化成(03759.HK)目標價177元 評級「買入」
阿思達克 01-11 14:47
裏昂發表報告表示,以2020年度收入計,康龍化成(03759.HK)爲內地第二大小份子藥物研發合同研究機構(CRO),且提供實驗室到製造整合服務;公司擁有超過15年的經營經驗,在覈心實驗室服務方面擁有豐富的經驗,並正在擴展到後期CMC(化學、製造和控制)服務。 該行認爲,未來兩至三年實驗室服務仍是主要增長動力,而CMC的增長潛力尚未反映,故將其2021至2023年度收入預測上調15%至36%,以反映CMC及新業務帶來的潛在收入貢獻,目標價相應由165.87元升至177元,重申「買入」評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account